Correction: Sugiyama, K.; et al. Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment. Diseases 2018, 6 , 44

摘要

The authors wish to make the following changes to their paper [1]. In Table 1, in the last row,the authors reported rates of Neutralizing antibodies: 42% vs. 6% in ODYSSEY Outcomes. Actually,these are patient numbers and not percentages. Due to this fact, we would like to correct this data as0.4% vs. 0.1% in Table 1. This correction has been made in both Table 1 and in the main text.